Connect with us

5 Small Cap Stocks Analysts Say To Buy With Targets Up To 300%

Small Caps to buy according to analysts with price targets up to 300% right now…

Published

on

Analysts Are Bullish On These Penny Stocks

Finding penny stocks to buy doesn’t have to be overly complicated. Research is a big part of identifying trends and opportunities early. Sometimes analysts can be helpful in adding some insight to your DD process. In this article, we will take a look at 5 penny stocks with buy ratings from analysts. They’ve also bullish price targets, with some fetching more than 100% right now. Even with bullish analyst ratings, it’s important to understand how to trade penny stocks in the first place. So if you’re brand new, check out Penny Stocks Trading for Beginners [2021].

Penny Stocks To Buy According To Analysts

Once you find your strategy, it’s good to put it to use. And if you can find that your thesis aligns with analysts and their outlook, it may be worth paying attention a bit more closely.

1. Safe Bulkers Inc. (NYSE: SB)

With the global supply chain issues, the shipping industry has become a big focus for investors. Despite the hiccups, constant demand is driving up valuations for these companies. Safe Bulkers (NYSE: SB) handles dry bulk transport services for its customers.

Recent SB Stock News

The most recent news from Safe Bulkers came earlier in August. The company announced a deal for a 12-month bareboat charter agreement for the delivery of a vessel by the end of the fourth quarter this year. At the end of the chart period, the company has the option to purchase the vessel for $18 million.

Analyst Outlook

The last Buy rating on SB stock came from Stiefel Nicolaus. At the time the rating was given, shares were still trading below $2. So the $3 target was a premium. As of this week, shares of SB are trading well above this level and have broken back above the 50-day moving average for the first time since July.
penny stocks to buy analyst ratings Safe Bulkers SB stock chart

2. Xenetic Biosciences Inc. (NASDAQ: XBIO)

Biotech remains a core focus for traders in the stock market today. Small-caps, in particular, are frequent beneficiaries of speculative momentum. In this case, Xenetic Biosciences (NASDAQ: XBIO) has seen a surge of interest in trading over the last few weeks. The company’s CAR T platform, XCART, is being designed for targeted, tumor-specific therapy.

Recent XBIO Stock News

Aside from raising several million dollars over the last few weeks, Xenetic recently reported its second-quarter results & business update. In it, CEO Jeffrey Eisenberg explained, “Over the course of the second quarter, we continued to execute our innovative and differentiated XCART program, and the technical progress we’ve accomplished brings us closer to the critical milestone of conducting IND-enabling studies in the United States. In light of that progress, we are taking important steps to validate the key workflow and manufacturing components that we believe will maximize the XCART opportunity.”

Analyst Outlook

The most recent Buy rating on XBIO stock comes from HC Wainwright. The firm also placed a $5 price target on the stock, 57% higher than current trading levels. Analysts Joseph Pantginis said he expects a “meaningful visibility boost” from the XCART program.
penny stocks to buy analyst ratings Xenetic Biosciences XBIO stock chart

3. Verb Technology (NASDAQ: VERB)

One of the technology penny stocks gaining ground this quarter is Verb Technology (NASDAQ: VERB). The penny stock’s shares initially took off earlier this summer thanks to growing interest in Verb’s live streaming eCommerce platform, verbLIVE. Since then, VERB stock has jumped from under $1.50 to nearly y$4 and currently trades right around $2 during August. Read More: Top Penny Stocks to Buy? Here’s 3 That Investors Are Watching

Recent VERB stock News

While the price of VERB stock has slid from its summer highs, trading activity hasn’t slowed much. That may have to do with recent events from the company. This week, Verb announced that its CEO Rory Cutaia will present at the Sidoti August Microcap Conference. Since that conference is being held as we speak (August 18th-19th), there could be some focus on the company’s platforms. In particular, recent milestones, including the release of verbMAIL, an interactive video email platform, will be in these discussions. Furthermore, Cutaia is planning to discuss recent partnerships with the likes of Market America Worldwide | Shop.com and NewAge Inc.

Analyst Outlook

The latest rating from Alliance Global set the stage for the VERB stock forecast from analysts. The firm has a Buy rating along with a $4 price target. This was increased from its previous target of $2.75. Analysts Brian Kinstlinger expressed that he thought the company was past a difficult 2-year technology development stage and the pandemic’s boost to video and streaming has “emerged as a critical communication medium” and how “verbLIVE, verbMAIL, and eventually Verb’s marketplace position the company to benefit from this trend.”
penny stocks to buy analyst ratings Verb Technology VERB stock chart

4. Senseonics Holdings Inc. (NYSE: SENS)

Similar to some of the other companies discussed above, Senseonics (NYSE: SENS) has also steadily climbed this year. The medical technology company focuses on commercializing implantable continuous glucose monitoring systems for diabetes patients. A current PROMISE study is being conducted to evaluate the safety and accuracy of its Eversense CGM System.

Recent SENS Stock News

Like most companies right now, the focus is on earnings. In Senseonics’ case, it came up a bit short on earnings per share but beat sales estimates for the quarter. Furthermore, the company guided that fiscal 2021 sales should come in between $12 million and $15 million. Read more: 4 Trending Penny Stocks On Robinhood You Should Watch Right Now Tim Goodnow, Ph.D., President and Chief Executive Officer of Senseonics, said, “As announced when we submitted this data to the FDA, we are pleased with the strength of the data from the PROMISE Study, which we believe represents a top tier CGM safety and accuracy profile. Along with our commercial partner Ascensia Diabetes Care, we are excited about the opportunity to offer more patients the longest-lasting CGM systems.”

Analyst Outlook

Colliers Securities recently reiterated its Buy rating on the stock. Furthermore, analyst Kyle Bauser set a price target of $4 on the penny stock. Based on current prices, that’s roughly 26% higher than the current trading levels.
penny stocks to buy analyst ratings Senseonics Holdings SENS stock chart

5. Kadmon Holdings Inc. (NASDAQ: KDMN)

With a strong move over the last month, Kadmon Holdings (NASDAQ: KDMN) has turned plenty of heads in the stock market. Today, KDMN stock continued this trend and tested the upper limits of the penny stock range. The biotech company focuses on developing drugs for unmet needs, including its REZUROCK tablet for cGVHD (Chronic Graft-versus-Host Disease) in pediatric patients.

Recent KDMN Stock News

Similar to Sensionics, Kadmon also recently put out its latest quarterly report. In it, the company highlighted its REZUROCK progress. CEO Harlan W. Waksal, M.D. said, “The recent U.S. FDA approval of REZUROCK marked a transformative event for Kadmon and for patients living with cGVHD. REZUROCK represents a paradigm shift in the cGVHD treatment landscape by uniquely addressing both the immune and fibrotic components of the disease.” The company has also focused on other indications for its REZUROCK (belumosudil) for treating systemic sclerosis. An open-label Phase 2 trial is expected by the end of the year. In addition, Kadmon’s KD033 platform in cancer is set for data to be reported from its current trial next quarter.

Analyst Outlook

When it comes to KDMN stock, HC Wainwright analysts are in focus. The firm’s Andrew Fein gave a Buy rating on the stock. He also set a price target of $20. Based on current trading levels, that target is roughly 300% higher right now.
penny stocks to buy analyst ratings Kadmon Holdings KDMN stock chart

Can You Make Money With Penny Stocks?

Regardless of what the masses may presume, you can make money with penny stocks. Though analysts may be bullish or bearish, it’s ultimately up to you to decide if something shows potential. Looking at things like financials, recent news, and, yes, analyst commentary can help you put together an initial thesis to build off of. The post 5 Penny Stocks Analysts Say To Buy With Targets Up To 300% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading

Government

Survey Shows Declining Concerns Among Americans About COVID-19

Survey Shows Declining Concerns Among Americans About COVID-19

A new survey reveals that only 20% of Americans view covid-19 as "a major threat"…

Published

on

Survey Shows Declining Concerns Among Americans About COVID-19

A new survey reveals that only 20% of Americans view covid-19 as "a major threat" to the health of the US population - a sharp decline from a high of 67% in July 2020.

(SARMDY/Shutterstock)

What's more, the Pew Research Center survey conducted from Feb. 7 to Feb. 11 showed that just 10% of Americans are concerned that they will  catch the disease and require hospitalization.

"This data represents a low ebb of public concern about the virus that reached its height in the summer and fall of 2020, when as many as two-thirds of Americans viewed COVID-19 as a major threat to public health," reads the report, which was published March 7.

According to the survey, half of the participants understand the significance of researchers and healthcare providers in understanding and treating long COVID - however 27% of participants consider this issue less important, while 22% of Americans are unaware of long COVID.

What's more, while Democrats were far more worried than Republicans in the past, that gap has narrowed significantly.

"In the pandemic’s first year, Democrats were routinely about 40 points more likely than Republicans to view the coronavirus as a major threat to the health of the U.S. population. This gap has waned as overall levels of concern have fallen," reads the report.

More via the Epoch Times;

The survey found that three in ten Democrats under 50 have received an updated COVID-19 vaccine, compared with 66 percent of Democrats ages 65 and older.

Moreover, 66 percent of Democrats ages 65 and older have received the updated COVID-19 vaccine, while only 24 percent of Republicans ages 65 and older have done so.

“This 42-point partisan gap is much wider now than at other points since the start of the outbreak. For instance, in August 2021, 93 percent of older Democrats and 78 percent of older Republicans said they had received all the shots needed to be fully vaccinated (a 15-point gap),” it noted.

COVID-19 No Longer an Emergency

The U.S. Centers for Disease Control and Prevention (CDC) recently issued its updated recommendations for the virus, which no longer require people to stay home for five days after testing positive for COVID-19.

The updated guidance recommends that people who contracted a respiratory virus stay home, and they can resume normal activities when their symptoms improve overall and their fever subsides for 24 hours without medication.

“We still must use the commonsense solutions we know work to protect ourselves and others from serious illness from respiratory viruses, this includes vaccination, treatment, and staying home when we get sick,” CDC director Dr. Mandy Cohen said in a statement.

The CDC said that while the virus remains a threat, it is now less likely to cause severe illness because of widespread immunity and improved tools to prevent and treat the disease.

Importantly, states and countries that have already adjusted recommended isolation times have not seen increased hospitalizations or deaths related to COVID-19,” it stated.

The federal government suspended its free at-home COVID-19 test program on March 8, according to a website set up by the government, following a decrease in COVID-19-related hospitalizations.

According to the CDC, hospitalization rates for COVID-19 and influenza diseases remain “elevated” but are decreasing in some parts of the United States.

Tyler Durden Sun, 03/10/2024 - 22:45

Read More

Continue Reading

International

Rand Paul Teases Senate GOP Leader Run – Musk Says “I Would Support”

Rand Paul Teases Senate GOP Leader Run – Musk Says "I Would Support"

Republican Kentucky Senator Rand Paul on Friday hinted that he may jump…

Published

on

Rand Paul Teases Senate GOP Leader Run - Musk Says "I Would Support"

Republican Kentucky Senator Rand Paul on Friday hinted that he may jump into the race to become the next Senate GOP leader, and Elon Musk was quick to support the idea. Republicans must find a successor for periodically malfunctioning Mitch McConnell, who recently announced he'll step down in November, though intending to keep his Senate seat until his term ends in January 2027, when he'd be within weeks of turning 86. 

So far, the announced field consists of two quintessential establishment types: John Cornyn of Texas and John Thune of South Dakota. While John Barrasso's name had been thrown around as one of "The Three Johns" considered top contenders, the Wyoming senator on Tuesday said he'll instead seek the number two slot as party whip. 

Paul used X to tease his potential bid for the position which -- if the GOP takes back the upper chamber in November -- could graduate from Minority Leader to Majority Leader. He started by telling his 5.1 million followers he'd had lots of people asking him about his interest in running...

...then followed up with a poll in which he predictably annihilated Cornyn and Thune, taking a 96% share as of Friday night, with the other two below 2% each. 

Elon Musk was quick to back the idea of Paul as GOP leader, while daring Cornyn and Thune to follow Paul's lead by throwing their names out for consideration by the Twitter-verse X-verse. 

Paul has been a stalwart opponent of security-state mass surveillance, foreign interventionism -- to include shoveling billions of dollars into the proxy war in Ukraine -- and out-of-control spending in general. He demonstrated the latter passion on the Senate floor this week as he ridiculed the latest kick-the-can spending package:   

In February, Paul used Senate rules to force his colleagues into a grueling Super Bowl weekend of votes, as he worked to derail a $95 billion foreign aid bill. "I think we should stay here as long as it takes,” said Paul. “If it takes a week or a month, I’ll force them to stay here to discuss why they think the border of Ukraine is more important than the US border.”

Don't expect a Majority Leader Paul to ditch the filibuster -- he's been a hardy user of the legislative delay tactic. In 2013, he spoke for 13 hours to fight the nomination of John Brennan as CIA director. In 2015, he orated for 10-and-a-half-hours to oppose extension of the Patriot Act

Rand Paul amid his 10 1/2 hour filibuster in 2015

Among the general public, Paul is probably best known as Capitol Hill's chief tormentor of Dr. Anthony Fauci, who was director of the National Institute of Allergy and Infectious Disease during the Covid-19 pandemic. Paul says the evidence indicates the virus emerged from China's Wuhan Institute of Virology. He's accused Fauci and other members of the US government public health apparatus of evading questions about their funding of the Chinese lab's "gain of function" research, which takes natural viruses and morphs them into something more dangerous. Paul has pointedly said that Fauci committed perjury in congressional hearings and that he belongs in jail "without question."   

Musk is neither the only nor the first noteworthy figure to back Paul for party leader. Just hours after McConnell announced his upcoming step-down from leadership, independent 2024 presidential candidate Robert F. Kennedy, Jr voiced his support: 

In a testament to the extent to which the establishment recoils at the libertarian-minded Paul, mainstream media outlets -- which have been quick to report on other developments in the majority leader race -- pretended not to notice that Paul had signaled his interest in the job. More than 24 hours after Paul's test-the-waters tweet-fest began, not a single major outlet had brought it to the attention of their audience. 

That may be his strongest endorsement yet. 

Tyler Durden Sun, 03/10/2024 - 20:25

Read More

Continue Reading

Government

The Great Replacement Loophole: Illegal Immigrants Score 5-Year Work Benefit While “Waiting” For Deporation, Asylum

The Great Replacement Loophole: Illegal Immigrants Score 5-Year Work Benefit While "Waiting" For Deporation, Asylum

Over the past several…

Published

on

The Great Replacement Loophole: Illegal Immigrants Score 5-Year Work Benefit While "Waiting" For Deporation, Asylum

Over the past several months we've pointed out that there has  been zero job creation for native-born workers since the summer of 2018...

... and that since Joe Biden was sworn into office, most of the post-pandemic job gains the administration continuously brags about have gone foreign-born (read immigrants, mostly illegal ones) workers.

And while the left might find this data almost as verboten as FBI crime statistics - as it directly supports the so-called "great replacement theory" we're not supposed to discuss - it also coincides with record numbers of illegal crossings into the United States under Biden.

In short, the Biden administration opened the floodgates, 10 million illegal immigrants poured into the country, and most of the post-pandemic "jobs recovery" went to foreign-born workers, of which illegal immigrants represent the largest chunk.

Asylum seekers from Venezuela await work permits on June 28, 2023 (via the Chicago Tribune)

'But Tyler, illegal immigrants can't possibly work in the United States whilst awaiting their asylum hearings,' one might hear from the peanut gallery. On the contrary: ever since Biden reversed a key aspect of Trump's labor policies, all illegal immigrants - even those awaiting deportation proceedings - have been given carte blanche to work while awaiting said proceedings for up to five years...

... something which even Elon Musk was shocked to learn.

Which leads us to another question: recall that the primary concern for the Biden admin for much of 2022 and 2023 was soaring prices, i.e., relentless inflation in general, and rising wages in particular, which in turn prompted even Goldman to admit two years ago that the diabolical wage-price spiral had been unleashed in the US (diabolical, because nothing absent a major economic shock, read recession or depression, can short-circuit it once it is in place).

Well, there is one other thing that can break the wage-price spiral loop: a flood of ultra-cheap illegal immigrant workers. But don't take our word for it: here is Fed Chair Jerome Powell himself during his February 60 Minutes interview:

PELLEY: Why was immigration important?

POWELL: Because, you know, immigrants come in, and they tend to work at a rate that is at or above that for non-immigrants. Immigrants who come to the country tend to be in the workforce at a slightly higher level than native Americans do. But that's largely because of the age difference. They tend to skew younger.

PELLEY: Why is immigration so important to the economy?

POWELL: Well, first of all, immigration policy is not the Fed's job. The immigration policy of the United States is really important and really much under discussion right now, and that's none of our business. We don't set immigration policy. We don't comment on it.

I will say, over time, though, the U.S. economy has benefited from immigration. And, frankly, just in the last, year a big part of the story of the labor market coming back into better balance is immigration returning to levels that were more typical of the pre-pandemic era.

PELLEY: The country needed the workers.

POWELL: It did. And so, that's what's been happening.

Translation: Immigrants work hard, and Americans are lazy. But much more importantly, since illegal immigrants will work for any pay, and since Biden's Department of Homeland Security, via its Citizenship and Immigration Services Agency, has made it so illegal immigrants can work in the US perfectly legally for up to 5 years (if not more), one can argue that the flood of illegals through the southern border has been the primary reason why inflation - or rather mostly wage inflation, that all too critical component of the wage-price spiral  - has moderated in in the past year, when the US labor market suddenly found itself flooded with millions of perfectly eligible workers, who just also happen to be illegal immigrants and thus have zero wage bargaining options.

None of this is to suggest that the relentless flood of immigrants into the US is not also driven by voting and census concerns - something Elon Musk has been pounding the table on in recent weeks, and has gone so far to call it "the biggest corruption of American democracy in the 21st century", but in retrospect, one can also argue that the only modest success the Biden admin has had in the past year - namely bringing inflation down from a torrid 9% annual rate to "only" 3% - has also been due to the millions of illegals he's imported into the country.

We would be remiss if we didn't also note that this so often carries catastrophic short-term consequences for the social fabric of the country (the Laken Riley fiasco being only the latest example), not to mention the far more dire long-term consequences for the future of the US - chief among them the trillions of dollars in debt the US will need to incur to pay for all those new illegal immigrants Democrat voters and low-paid workers. This is on top of the labor revolution that will kick in once AI leads to mass layoffs among high-paying, white-collar jobs, after which all those newly laid off native-born workers hoping to trade down to lower paying (if available) jobs will discover that hardened criminals from Honduras or Guatemala have already taken them, all thanks to Joe Biden.

Tyler Durden Sun, 03/10/2024 - 19:15

Read More

Continue Reading

Trending